ASSESSING THE COMPARATIVE EFFICACY OF INP104 FOR ACUTE TREATMENT OF MIGRAINE ATTACKS: A MATCHING-ADJUSTED INDIRECT COMPARISON

被引：0
|
作者：
Joshi, S. [1 ]
Aurora, S. K. [2 ]
Wang, S. [3 ]
Park, J. E. [4 ]
Wu, P. [4 ]
Keeping, S. T. [4 ]
Bariahtaris, S. [2 ]
Shrewsbury, S. [2 ]
机构：
[1] Dent Neurol Inst, Amherst, NY USA
[2] Impel NeuroPharma Inc, Seattle, WA USA
[3] Precis HEOR, W Vancouver, BC, Canada
[4] Precis HEOR, Vancouver, BC, Canada
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND7
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [31] SECUKINUMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: COMPARATIVE EFFECTIVENESS RESULTS VERSUS ADALIMUMAB USING A MATCHING-ADJUSTED INDIRECT COMPARISON
    Maksymowych, W.
    Strand, V
    Baeten, D.
    Nash, P.
    Thom, H.
    Hunger, M.
    Gandhi, K.
    Richards, H.
    Jugl, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 782 - 782
  • [32] SECUKINUMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: COMPARATIVE EFFECTIVENESS RESULTS VERSUS ADALIMUMAB USING A MATCHING-ADJUSTED INDIRECT COMPARISON
    Maksymowych, W.
    Strand, V.
    Baeten, D.
    Nash, P.
    Thom, H.
    Cure, S.
    Palaka, E.
    Gandhi, K.
    Richards, H.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 98 - 98
  • [33] COMPARATIVE EFFICACY AND SAFETY OF OZANIMOD VERSUS TERIFLUNOMIDE FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS: A MATCHING-ADJUSTED INDIRECT COMPARISON
    Cohan, S.
    Kumar, J.
    Arndorfer, S.
    Zhu, X.
    Zivkovic, M.
    Tencer, T.
    VALUE IN HEALTH, 2020, 23 : S624 - S624
  • [34] PERFORMANCE COMPARISON OF UNANCHORED MATCHING-ADJUSTED INDIRECT COMPARISON AND NAIVE TREATMENT INDIRECT COMPARISON ON SURVIVAL OUTCOMES: A SIMULATION STUDY
    Liu, Y.
    Liu, J.
    He, X.
    Wu, J.
    VALUE IN HEALTH, 2022, 25 (12) : S366 - S366
  • [35] Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis
    Cohan, Stanley
    Tencer, Tom
    Arndorfer, Stella
    Zhu, Xuelian
    Zivkovic, Marko
    Kumar, Jinender
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [36] Comparative Efficacy of Ibrutinib Versus Obinutuzumab plus Chlorambucil in First-Line Treatment of Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison
    Van Sanden, Suzy
    Baculea, Simona
    Diels, Joris
    Cote, Sarah
    ADVANCES IN THERAPY, 2017, 34 (07) : 1650 - 1661
  • [37] MATCHING-ADJUSTED INDIRECT TREATMENT COMPARISON BETWEEN LANADELUMAB AND BEROTRALSTAT FOR HEREDITARY ANGIOEDEMA PROPHYLAXIS
    Watt, M.
    Malmenas, M.
    Romanus, D.
    Haeussler, K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S26 - S26
  • [38] Relative efficacy of adalimumab versus secukinumab in active psoriatic arthritis: A matching-adjusted indirect comparison
    Betts, Keith
    Mittal, Manish
    Joshi, Avani
    Song, Jinlin
    Bao, Yanjun
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB267 - AB267
  • [39] RELATIVE EFFICACY OF ADALIMUMAB VERSUS SECUKINUMAB IN ACTIVE ANKYLOSING SPONDYLITIS: A MATCHING-ADJUSTED INDIRECT COMPARISON
    Betts, K. A.
    Mittal, M.
    Song, J.
    Skup, M.
    Joshi, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 98 - 99
  • [40] Matching-adjusted indirect comparison for treatment of NTRK fusion cancer with larotrectinib versus entrectinib
    Garcia-Foncillas, J.
    Bokemeyer, C.
    Italiano, A.
    Keating, K.
    Paracha, N.
    Fellous, M.
    Marian, M.
    Fillbrunn, M.
    Gao, W.
    Ayyagari, R.
    Lassen, U. N.
    ANNALS OF ONCOLOGY, 2021, 32 : S401 - S401
12345